Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protecting Late-moderate Preterm Infants From Respiratory Tract Infections and Wheeze in Their First Years of Life by Using Bacterial Lysates.

NCT05063149 is registered in ClinicalTrials.gov with Franciscus Gasthuis as lead sponsor.

NCT NCT05063149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05063149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protecting Late-moderate Preterm Infants From Respiratory Tract Infections and Wheeze in Their First Years of Life by Using Bacterial Lysates.
Lead sponsor
Franciscus Gasthuis
Phase
Phase 3
Overall status
Recruiting
Start date
March 18, 2022
Completion date
December 31, 2030
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lrti, premature, wheezing